Evidence map›Paper›PMID 36872400›Full record

Trial reportScientific reports2023

Sniffer dogs performance is stable over time in detecting COVID-19 positive samples and agrees with the rapid antigen test in the field.

Federica Pirrone, Patrizia Piotti, Massimo Galli, Roberto Gasparri, Aldo La Spina, Lorenzo Spaggiari, Mariangela Albertini

Open access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Scientific reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.4field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Federica PirroneDepartment of Veterinary Medicine and Animal Sciences, University of Milan (UNIMI), 26900, Lodi, Italy.
Patrizia PiottiDepartment of Veterinary Medicine and Animal Sciences, University of Milan (UNIMI), 26900, Lodi, Italy. patrizia.piotti1@unimi.it.
Massimo GalliIII Infectious Diseases Unit, L. Sacco Hospital, ASST Fatebenefratelli-Sacco, 20157, Milan, Italy.
Roberto GasparriDivision of Thoracic Surgery, IEO, European Institute of Oncology IRCCS, Milan, Italy.
Aldo La SpinaMedical Detection Dogs Italy, Novate milanese, Italy.
Lorenzo SpaggiariDivision of Thoracic Surgery, IEO, European Institute of Oncology IRCCS, Milan, Italy.
Mariangela AlbertiniDepartment of Veterinary Medicine and Animal Sciences, University of Milan (UNIMI), 26900, Lodi, Italy.
University of Milan · ITASST Fatebenefratelli Sacco · ITEuropean Institute of Oncology · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Rapid antigen diagnostic (RAD) tests have been developed for the identification of the SARS-CoV-2 infection. However, they require nasopharyngeal or nasal swab, which is invasive, uncomfortable, and aerosolising. The use of saliva test was also proposed but has not yet been validated. Trained dogs may efficiently smell the presence of SARS-CoV-2 in biological samples of infected people, but further validation is needed both in laboratory and in field. The present study aimed to (1) assess and validate the stability over a specific time period of COVID-19 detection in humans' armpit sweat by trained dogs thanks to a double-blind laboratory test-retest design, and (2) assess this ability when sniffing people directly. Dogs were not trained to discriminate against other infections. For all dogs (n. 3), the laboratory test on 360 samples yielded 93% sensitivity and 99% specificity, an 88% agreement with the Rt-PCR, and a moderate to strong test-retest correlation. When sniffing people directly (n. 97), dogs' (n. 5) overall sensitivity (89%) and specificity (95%) were significantly above chance level. An almost perfect agreement with RAD results was found (kappa 0.83, SE 0.05, p = 0.001). Therefore, sniffer dogs met appropriate criteria (e.g., repeatability) and WHO's target product profiles for COVID-19 diagnostics and produced very promising results in laboratory and field settings, respectively. These findings support the idea that biodetection dogs could help reduce the spread of the virus in high-risk environments, including airports, schools, and public transport.

Indexed as

COVID-19AirportsAnimalsDogsHumansImmunologic TestsSARS-CoV-2Working Dogs

Identifiers

PMID36872400
PMCPMC9985821
OpenAlexW4323268372

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.